BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 37820312)

  • 1. Cuproptosis: Harnessing Transition Metal for Cancer Therapy.
    Wang W; Mo W; Hang Z; Huang Y; Yi H; Sun Z; Lei A
    ACS Nano; 2023 Oct; 17(20):19581-19599. PubMed ID: 37820312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Copper metabolism and cuproptosis in human malignancies: Unraveling the complex interplay for therapeutic insights.
    Abdullah KM; Kaushal JB; Takkar S; Sharma G; Alsafwani ZW; Pothuraju R; Batra SK; Siddiqui JA
    Heliyon; 2024 Mar; 10(5):e27496. PubMed ID: 38486750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Copper homeostasis and cuproptosis in mitochondria.
    Tian Z; Jiang S; Zhou J; Zhang W
    Life Sci; 2023 Dec; 334():122223. PubMed ID: 38084674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting cuproplasia and cuproptosis in cancer.
    Tang D; Kroemer G; Kang R
    Nat Rev Clin Oncol; 2024 May; 21(5):370-388. PubMed ID: 38486054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of lipid metabolism on cuproptosis-inducing cancer therapy.
    Zhong Y; Zeng W; Chen Y; Zhu X
    Biomed Pharmacother; 2024 Mar; 172():116247. PubMed ID: 38330710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Copper homeostasis and cuproptosis in cancer immunity and therapy.
    Liu WQ; Lin WR; Yan L; Xu WH; Yang J
    Immunol Rev; 2024 Jan; 321(1):211-227. PubMed ID: 37715546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cuproptosis: A novel therapeutic target for overcoming cancer drug resistance.
    Wang Y; Chen Y; Zhang J; Yang Y; Fleishman JS; Wang Y; Wang J; Chen J; Li Y; Wang H
    Drug Resist Updat; 2024 Jan; 72():101018. PubMed ID: 37979442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Copper homeostasis and cuproptosis in health and disease.
    Chen L; Min J; Wang F
    Signal Transduct Target Ther; 2022 Nov; 7(1):378. PubMed ID: 36414625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cuproptosis: unveiling a new frontier in cancer biology and therapeutics.
    Feng Y; Yang Z; Wang J; Zhao H
    Cell Commun Signal; 2024 May; 22(1):249. PubMed ID: 38693584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Research progress in cuproptosis in liver cancer.
    Chen L; Liu D; Tan Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Sept 28; 48(9):1368-1376. PubMed ID: 38044648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interplay of Ferroptosis and Cuproptosis in Cancer: Dissecting Metal-Driven Mechanisms for Therapeutic Potentials.
    Wang J; Li J; Liu J; Chan KY; Lee HS; Lin KN; Wang CC; Lau TS
    Cancers (Basel); 2024 Jan; 16(3):. PubMed ID: 38339263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cuproptosis: mechanisms and links with cancers.
    Xie J; Yang Y; Gao Y; He J
    Mol Cancer; 2023 Mar; 22(1):46. PubMed ID: 36882769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crosstalk between ferroptosis and cuproptosis: From mechanism to potential clinical application.
    Liu N; Chen M
    Biomed Pharmacother; 2024 Feb; 171():116115. PubMed ID: 38181713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cuproptosis in lung cancer: therapeutic options and prognostic models.
    Jawed R; Bhatti H
    Apoptosis; 2024 May; ():. PubMed ID: 38735011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles and mechanisms of copper homeostasis and cuproptosis in osteoarticular diseases.
    Han J; Luo J; Wang C; Kapilevich L; Zhang XA
    Biomed Pharmacother; 2024 May; 174():116570. PubMed ID: 38599063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cuproptosis: Mechanism, role, and advances in urological malignancies.
    Wu J; He J; Liu Z; Zhu X; Li Z; Chen A; Lu J
    Med Res Rev; 2024 Jul; 44(4):1662-1682. PubMed ID: 38299968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cuproptosis in cancers: Function and implications from bench to bedside.
    Huang XY; Shen JY; Huang K; Wang L; Sethi G; Ma Z
    Biomed Pharmacother; 2024 Jul; 176():116874. PubMed ID: 38850661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Copper homeostasis and cuproptosis in gynecological disorders: Pathogenic insights and therapeutic implications.
    Lin Y; Yuan M; Wang G
    J Trace Elem Med Biol; 2024 Jul; 84():127436. PubMed ID: 38547725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel insights into anticancer mechanisms of elesclomol: More than a prooxidant drug.
    Gao J; Wu X; Huang S; Zhao Z; He W; Song M
    Redox Biol; 2023 Nov; 67():102891. PubMed ID: 37734229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cope with copper: From copper linked mechanisms to copper-based clinical cancer therapies.
    Wang X; Zhou M; Liu Y; Si Z
    Cancer Lett; 2023 May; 561():216157. PubMed ID: 37011869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.